Apellis Pharmaceuticals (NasdaqGS:APLS) 2025 Conference November 12, 2025 02:40 PM ET Speaker0We're live. Good afternoon, everyone, and welcome to the Apellis session. It's our pleasure to have CFO Tim Sullivan and Chief Commercial Officer David Acheson with us today. It's at a time when Syfovre, I would say, is reaching a more mature phase, but you've got a new product or a new indication for Empaveli, which is hopefully bringing some life back into sales growth. Why don't I just let you have the floor for ...